KRYSTAL BIOTECH INC. - COMMON STOCK

Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB

26 апр 2021 16:05:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline

19 апр 2021 08:00:01 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa

30 мар 2021 08:00:02 Источник Nasdaq GlobeNewswire

Krystal Biotech to Participate in Upcoming Investor Conferences

29 мар 2021 16:30:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications

24 мар 2021 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and Full Year 2020 Financial Results

01 мар 2021 08:37:30 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at the Cowen 41st Annual Health Care Conference

23 фев 2021 08:00:01 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock

02 фев 2021 20:50:57 Источник Nasdaq GlobeNewswire